{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:50:04Z","timestamp":1792273804498,"version":"4.4.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016971","name":"Lomonosov Moscow State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bioorg.2022.105904","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T11:18:56Z","timestamp":1654255136000},"page":"105904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Synthesis and evaluation of avermectin\u2013imidazo[1,2-a]pyridine hybrids as potent GABAA receptor modulators"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8554-838X","authenticated-orcid":false,"given":"Yulia A.","family":"Volkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina V.","family":"Rassokhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeny A.","family":"Kondrakhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey V.","family":"Rossokhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey N.","family":"Kolbaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana B.","family":"Tihonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamedsalim","family":"Kh. Dzhafarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Schetinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena I.","family":"Chernoburova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina V.","family":"Vasileva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey S.","family":"Dmitrenok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy I.","family":"Kovalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina N.","family":"Sharonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Zavarzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/138920112800399095","article-title":"History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents","volume":"13","author":"Campbell","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/acve-2017-0013","article-title":"A brief review on the mode of action of antinematodal drugs","volume":"67","author":"Abongwa","year":"2017","journal-title":"Acta veterinaria"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/09168451.2016.1248368","article-title":"Continuing fascination of exploration in natural substances from microorganisms","volume":"81","author":"Takahashi","year":"2017","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0020","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/138920112800399158","article-title":"Avermectin use in aquaculture","volume":"13","author":"Tor","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105904_b0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/ph13080196","article-title":"Avermectin derivatives, pharmacokinetics, therapeutic and toxic dosages, mechanism of action, and their biological effects","volume":"13","author":"El-Saber Batiha","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0030","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/AAC.01696-12","article-title":"Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrug-resistant clinical strains","volume":"57","author":"Lim","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2022.105904_b0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fmicb.2019.00041","article-title":"Drug repurposing for the treatment of bacterial and fungal infections","volume":"10","author":"Mir\u00f3-Canturri","year":"2019","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.actatropica.2011.10.007","article-title":"Comparative evaluation of systemic drugs for their effects against Anopheles gambiae","volume":"121","author":"Butters","year":"2012","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2022.105904_b0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/DDDT.S237393","article-title":"Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin","volume":"14","author":"Liu","year":"2020","journal-title":"Drug Design, Development and Therapy"},{"issue":"18","key":"10.1016\/j.bioorg.2022.105904_b0050","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/blood-2010-01-262675","article-title":"The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells","volume":"116","author":"Sharmeen","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0055","first-page":"243","article-title":"Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines","volume":"3","author":"Hashimoto","year":"2009","journal-title":"Drug Discoveries & Therapeutics"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12917-019-2026-2","article-title":"Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling","volume":"15","author":"Diao","year":"2019","journal-title":"BMC Veterinary Research"},{"key":"10.1016\/j.bioorg.2022.105904_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"issue":"7","key":"10.1016\/j.bioorg.2022.105904_b0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00210-020-01902-5","article-title":"Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action","volume":"393","author":"Rizzo","year":"2020","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105904_b0075","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105904_b0080","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2924","article-title":"The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism","volume":"4","author":"Jin","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0090","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00213-018-4869-9","article-title":"Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders","volume":"235","author":"Khoja","year":"2018","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.alcohol.2015.03.006","article-title":"Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder","volume":"49","author":"Yardley","year":"2015","journal-title":"Alcohol"},{"issue":"8","key":"10.1016\/j.bioorg.2022.105904_b0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1751-0813.2009.00448.x","article-title":"Toxicity in three dogs from accidental oral administration of a topical endectocide containing moxidectin and imidacloprid","volume":"87","author":"See","year":"2009","journal-title":"Aust. Vet. J."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/138920112800399059","article-title":"Acute human toxicity of macrocyclic lactones","volume":"13","author":"Yang","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bioorg.2022.105904_b0110","series-title":"Ivermectin and abamectin","first-page":"1","author":"Campbell","year":"2012"},{"key":"10.1016\/j.bioorg.2022.105904_b0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pestbp.2014.11.006","article-title":"Novel GABA receptor pesticide targets","volume":"121","author":"Casida","year":"2015","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.bioorg.2022.105904_b0120","series-title":"Advances in pharmacology","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/bs.apha.2014.11.005","article-title":"Chapter Seven - Allosteric ligands and their binding sites define \u03b3-aminobutyric acid (GABA) type A receptor subtypes","author":"Olsen","year":"2015"},{"issue":"31","key":"10.1016\/j.bioorg.2022.105904_b0125","doi-asserted-by":"crossref","first-page":"10361","DOI":"10.1523\/JNEUROSCI.0441-14.2014","article-title":"Molecular and functional diversity of GABA-A receptors in the enteric nervous system of the mouse colon","volume":"34","author":"Seifi","year":"2014","journal-title":"J. Neuroscience: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.bioorg.2022.105904_b0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2016.00044","article-title":"Structural studies of GABAA receptor binding sites: Which experimental structure tells us what?","volume":"9","author":"Puthenkalam","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1476-5381.2011.01779.x","article-title":"A novel GABA(A) receptor pharmacology: drugs interacting with the \u03b1(+) \u03b2(-) interface","volume":"166","author":"Sieghart","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.105904_b0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnmol.2015.00055","article-title":"Functional characterization of ivermectin binding sites in alpha1beta2gamma2L GABA(A) receptors","volume":"8","author":"Estrada-Mondragon","year":"2015","journal-title":"Front. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105904_b0145","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2174\/156802611795371350","article-title":"GABAA receptor subtype-selective modulators. I. \u03b12\/\u03b13-selective agonists as non-sedating anxiolytics","volume":"11","author":"Atack","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2022.105904_b0150","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABAA receptors","volume":"39","author":"Sigel","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"7824","key":"10.1016\/j.bioorg.2022.105904_b0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2654-5","article-title":"Shared structural mechanisms of general anaesthetics and benzodiazepines","volume":"585","author":"Kim","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2022.105904_b0160","doi-asserted-by":"crossref","unstructured":"M. Cully, GABA. sub. A receptor structures solved, Nature reviews drug discovery 18(2) (2019) 98-99.","DOI":"10.1038\/d41573-019-00002-1"},{"issue":"26","key":"10.1016\/j.bioorg.2022.105904_b0165","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.2174\/1568026616666160506145539","article-title":"Medicinal attributes of imidazo[1, 2-a]pyridine derivatives: an update","volume":"16","author":"Devi","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2022.105904_b0175","series-title":"Homo and heterodimer ligands: The twin drug approach, The practice of medicinal chemistry","first-page":"380","author":"Contreras","year":"2008"},{"issue":"14","key":"10.1016\/j.bioorg.2022.105904_b0180","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm990946n","article-title":"Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis (9-amino-6-chloro-2-methoxyacridines): influence of the linker","volume":"43","author":"Girault","year":"2000","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105904_b0185","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1016\/j.ejmech.2009.02.024","article-title":"Recent developments in the design and synthesis of hybrid molecules basedon aminoquinoline ring and their antiplasmodial evaluation","volume":"44","author":"Kouznetsov","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105904_b0190","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejmech.2004.04.006","article-title":"Synthesis and antileishmanial activity of (1, 3-benzothiazol-2-yl)amino-9-(10H)-acridinone derivatives","volume":"39","author":"Delmas","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105904_b0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.10.035","article-title":"Quinoline and quinolone dimers and their biological activities: An overview","volume":"161","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105904_b0200","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejmech.2017.11.075","article-title":"Novel triazine dimers with potent antitrypanosomal activity","volume":"143","author":"Venkatraj","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105904_b0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0210","doi-asserted-by":"crossref","first-page":"28674","DOI":"10.1038\/srep28674","article-title":"Zolpidem is a potent stoichiometry-selective modulator of \u03b11\u03b23 GABAA receptors: evidence of a novel benzodiazepine site in the \u03b11-\u03b11 interface","volume":"6","author":"Che Has","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105904_b0215","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0028-3908(96)00057-3","article-title":"Inhibition of GABAA receptor chloride channel by quinolones and norfloxacin-biphenylacetic acid hybrid compounds","volume":"35","author":"Ito","year":"1996","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.bioorg.2022.105904_b0220","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1007\/s11172-016-1684-5","article-title":"Synthesis of 5,4\u2033-di-O-succinoylavermectin B1","volume":"65","author":"Chernoburova","year":"2016","journal-title":"Russ. Chem. Bull."},{"issue":"21","key":"10.1016\/j.bioorg.2022.105904_b0225","doi-asserted-by":"crossref","first-page":"11212","DOI":"10.1021\/acs.joc.5b02102","article-title":"Copper (II)-mediated aerobic synthesis of imidazo[1,2-a]pyridines via cascade aminomethylation\/cycloisomerization of alkynes","volume":"80","author":"Rassokhina","year":"2015","journal-title":"The journal of organic chemistry"},{"issue":"18","key":"10.1016\/j.bioorg.2022.105904_b0230","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1021\/acs.joc.7b01762","article-title":"Synthesis of imidazo[2, 1-b]thiazoles via copper-catalyzed A3-coupling in batch and continuous flow","volume":"82","author":"Rassokhina","year":"2017","journal-title":"The Journal of organic chemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)36590-5","article-title":"Avermectin B1a binds to high-and low-affinity sites with dual effects on the \u03b3-aminobutyric acid-gated chloride channel of cultured cerebellar granule neurons","volume":"281","author":"Huang","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0240","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1471-4159.1982.tb08639.x","article-title":"Avermectin B1a modulation of \u03b3-aminobutyric acid receptors in rat brain membranes","volume":"38","author":"Pong","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2022.105904_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103334","article-title":"Development of 1,3-thiazole analogues of imidazopyridines as potent positive allosteric modulators of GABAA receptors","volume":"94","author":"Tikhonova","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2022.105904_b0250","doi-asserted-by":"crossref","first-page":"11799","DOI":"10.1074\/jbc.272.18.11799","article-title":"Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site","volume":"272","author":"Buhr","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2022.105904_b0255","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.1073\/pnas.94.16.8824","article-title":"A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity","volume":"94","author":"Buhr","year":"1997","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.bioorg.2022.105904_b0260","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1124\/mol.52.5.874","article-title":"Key amino acids in the \u03b3 subunit of the \u03b3-aminobutyric acid A receptor that determine ligand binding and modulation at the benzodiazepine site","volume":"52","author":"Wingrove","year":"1997","journal-title":"Molecular Pharmacolology"},{"issue":"22","key":"10.1016\/j.bioorg.2022.105904_b0265","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1021\/jm800889m","article-title":"Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different","volume":"51","author":"Hanson","year":"2008","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/mol.106.029595","article-title":"Structural determinants for high-affinity zolpidem binding to GABA-A receptors","volume":"71","author":"Sancar","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.105904_b0275","doi-asserted-by":"crossref","unstructured":"W. Wisden, D.J. Laurie, H. Monyer, P.H. Seeburg, The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon, Journal of neuroscience 12(3) (1992) 1040-1062.","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0280","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cne.903260204","article-title":"Comparative molecular neuroanatomy of cloned GABAA receptor subunits in the rat CNS","volume":"326","author":"Persohn","year":"1992","journal-title":"Journal of comparative neurology"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0285","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A new benzodiazepine pharmacology","volume":"300","author":"M\u00f6hler","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105904_b0290","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABA-A receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0295","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-3908(95)00158-1","article-title":"Zolpidem functionally discriminates subtypes of native GABAA receptors in acutely dissociated rat striatal and cerebellar neurons","volume":"35","author":"Itier","year":"1996","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0300","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0014-2999(94)90500-2","article-title":"Effect of ivermectin on \u03b3-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones","volume":"259","author":"Kru","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105904_b0305","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0022-3565(24)39005-6","article-title":"Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the \u03b3-aminobutyric acidA receptor","volume":"295","author":"Dawson","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105904_b0310","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tips.2012.05.002","article-title":"Ivermectin binding sites in human and invertebrate Cys-loop receptors","volume":"33","author":"Lynagh","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105904_b0315","doi-asserted-by":"crossref","first-page":"e95072","DOI":"10.1371\/journal.pone.0095072","article-title":"Caenorhabditis elegans neuromuscular junction: GABA receptors and ivermectin action","volume":"9","author":"Hernando","year":"2014","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0320","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0026-895X(25)13064-2","article-title":"Effect of avermectin B1a on chick neuronal gamma-aminobutyrate receptor channels expressed in Xenopus oocytes","volume":"32","author":"Sigel","year":"1987","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105904_b0325","doi-asserted-by":"crossref","first-page":"e1883","DOI":"10.1371\/journal.pntd.0001883","article-title":"Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (\u2212\/\u2212) mice and effects on mammalian GABA (A) channel activity","volume":"6","author":"Menez","year":"2012","journal-title":"PLoS Negl.Trop. Dis."},{"issue":"13","key":"10.1016\/j.bioorg.2022.105904_b0330","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/bph.13754","article-title":"Zebrafish models in neuropsychopharmacology and CNS drug discovery","volume":"174","author":"Khan","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pbb.2009.07.009","article-title":"Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety","volume":"94","author":"Bencan","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105904_b0340","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/ALN.0000000000002281","article-title":"High-throughput screening in larval zebrafish identifies novel potent sedative-hypnotics","volume":"129","author":"Yang","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bioorg.2022.105904_b0345","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fphar.2015.00257","article-title":"Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers","volume":"6","author":"Nishimura","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105904_b0350","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/acs.jnatprod.7b00081","article-title":"HPLC-based activity profiling for GABAA receptor modulators in extracts: validation of an approach utilizing a larval zebrafish locomotor assay","volume":"80","author":"Moradi-Afrapoli","year":"2017","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105904_b0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/toxics4030019","article-title":"Zebrafish get connected: investigating neurotransmission targets and alterations in chemical toxicity","volume":"4","author":"Horzmann","year":"2016","journal-title":"Toxics"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2022.105904_b0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2003.10.024","article-title":"Identification and functional evidence of GABAergic neurons in parts of the brain of adult zebrafish (Danio rerio)","volume":"355","author":"Kim","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105904_b0365","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12311-008-0047-7","article-title":"Immunohistochemical localization of GABA, GAD65, and the receptor subunits GABA A\u03b11 and GABA B1 in the zebrafish cerebellum","volume":"7","author":"Delgado","year":"2008","journal-title":"The Cerebellum"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0370","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0952523808080322","article-title":"Electrophysiological evidence of GABAA and GABAC receptors on zebrafish retinal bipolar cells","volume":"25","author":"Connaughton","year":"2008","journal-title":"Vis. Neurosci."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105904_b0375","doi-asserted-by":"crossref","first-page":"e0196083","DOI":"10.1371\/journal.pone.0196083","article-title":"Expression of the eight GABAA receptor \u03b1 subunits in the developing zebrafish central nervous system","volume":"13","author":"Monesson-Olson","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2022.105904_b0380","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuroscience.2016.07.018","article-title":"Characterization of the \u03b3-aminobutyric acid signaling system in the zebrafish (Danio rerio Hamilton) central nervous system by reverse transcription-quantitative polymerase chain reaction","volume":"343","author":"Cocco","year":"2017","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0385","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00439-011-1128-0","article-title":"Zebrafish: a model for the study of addiction genetics","volume":"131","author":"Klee","year":"2012","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-84646-3","article-title":"Characterization of zebrafish GABAA receptor subunits","volume":"11","author":"Sadamitsu","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105904_b0395","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/nprot.2010.140","article-title":"Measuring behavioral and endocrine responses to novelty stress in adult zebrafish","volume":"5","author":"Cachat","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2022.105904_b0400","first-page":"3683","article-title":"A comparative study on the toxicity of ivermectin in zebra fish and catla fish models","author":"Thiripurasundari","year":"2014","journal-title":"Indo Am. J. Pharma. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105904_b0405","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10646-015-1607-5","article-title":"Effects of ivermectin on Danio rerio: a multiple endpoint approach: behaviour, weight and subcellular markers","volume":"25","author":"Domingues","year":"2016","journal-title":"Ecotoxicology"},{"issue":"5","key":"10.1016\/j.bioorg.2022.105904_b0410","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1089\/zeb.2014.1021","article-title":"Tolerance and efficacy of emamectin benzoate and ivermectin for the treatment of Pseudocapillaria tomentosa in laboratory zebrafish (Danio rerio)","volume":"11","author":"Collymore","year":"2014","journal-title":"Zebrafish"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0415","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/zeb.2012.0861","article-title":"Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond","volume":"10","author":"Kalueff","year":"2013","journal-title":"Zebrafish"},{"key":"10.1016\/j.bioorg.2022.105904_b0420","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fnmol.2012.00060","article-title":"Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin","volume":"5","author":"Lynagh","year":"2012","journal-title":"Front. Mol. Neurosci."},{"issue":"23","key":"10.1016\/j.bioorg.2022.105904_b0425","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1523\/JNEUROSCI.1012-11.2011","article-title":"Initiation of locomotion in adult zebrafish","volume":"31","author":"Kyriakatos","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105904_b0430","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/pr.115.012021","article-title":"Epilepsy, antiepileptic drugs, and aggression: an evidence-based review","volume":"68","author":"Brodie","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105904_b0435","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tins.2007.06.003","article-title":"The GABAA receptor: a novel target for treatment of fragile X?","volume":"30","author":"D\u2019Hulst","year":"2007","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0440","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coph.2005.08.005","article-title":"GABA-A receptors: a viable target for novel anxiolytics?","volume":"6","author":"Whiting","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"17\u201318","key":"10.1016\/j.bioorg.2022.105904_b0445","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.drudis.2009.06.009","article-title":"The complexity of the GABAA receptor shapes unique pharmacological profiles","volume":"14","author":"D\u2019Hulst","year":"2009","journal-title":"Drug Discovery Today"},{"issue":"7","key":"10.1016\/j.bioorg.2022.105904_b0450","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/17460441.2019.1599356","article-title":"GABA (A) receptor-targeted drug development-New perspectives in perioperative anesthesia","volume":"14","author":"Antkowiak","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2022.105904_b0455","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.sbi.2019.03.023","article-title":"A structural perspective on GABAA receptor pharmacology","volume":"54","author":"Scott","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105904_b0460","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.3390\/ijms21124445","article-title":"Regulation of GABAA receptor subunit expression in substance use disorders","volume":"21","author":"Barker","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105904_b0465","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2174\/1389557519666181210162003","article-title":"Hybrid molecules development: a versatile landscape for the control of antifungal drug resistance: a review","volume":"19","author":"Anusionwu","year":"2019","journal-title":"Mini Reviews Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105904_b0470","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/1568026616666160927150839","article-title":"Multi-target directed indole based hybrid molecules in cancer therapy: an up-to-date evidence-based review","volume":"17","author":"Sunil","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105904_b0475","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2174\/092986711795328355","article-title":"Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond","volume":"18","author":"Decker","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0480","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/jo961580e","article-title":"Building units for N-backbone cyclic peptides. 3. Synthesis of protected N \u03b1-(\u03c9-Aminoalkyl) amino acids and N \u03b1-(\u03c9-Carboxyalkyl) amino acids","volume":"62","author":"Muller","year":"1997","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2022.105904_b0485","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.steroids.2016.06.001","article-title":"Synthesis and antiproliferative activity evaluation of steroidal imidazo[1, 2-a]pyridines","volume":"113","author":"Rassokhina","year":"2016","journal-title":"Steroids"},{"issue":"17","key":"10.1016\/j.bioorg.2022.105904_b0490","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1021\/ol3020418","article-title":"Synthesis of imidazopyridines from the Morita\u2013Baylis\u2013Hillman acetates of nitroalkenes and convenient access to Alpidem and Zolpidem","volume":"14","author":"Nair","year":"2012","journal-title":"Org. Lett."},{"issue":"19","key":"10.1016\/j.bioorg.2022.105904_b0495","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1073\/pnas.84.19.6611","article-title":"Monte Carlo-minimization approach to the multiple-minima problem in protein folding","volume":"84","author":"Li","year":"1987","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2022.105904_b0500","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/BF00745970","article-title":"Vector method for calculating derivatives of energy of atom-atom interactions of complex molecules according to generalized coordinates","volume":"22","author":"Zhorov","year":"1981","journal-title":"J. Struct. Chem."},{"key":"10.1016\/j.bioorg.2022.105904_b0505","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/ja00315a051","article-title":"A new force field for molecular mechanical simulation of nucleic acids and proteins","volume":"106","author":"Weiner","year":"1984","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0510","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10822-009-9317-9","article-title":"Docking flexible ligands in proteins with a solvent exposure- and distance-dependent dielectric function","volume":"24","author":"Garden","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2022.105904_b0515","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1063\/1.449621","article-title":"Structural and energetic effects of truncating long ranged interactions in ionic polar fluids","volume":"83","author":"Brooks","year":"1985","journal-title":"J. Chem. Phys."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105904_b0520","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/mol.110.068031","article-title":"Why does the inner-helix mutation A413C double the stoichiometry of Kv1.3 channel block by emopamil but not by verapamil?","volume":"79","author":"Rossokhin","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105904_b0525","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1124\/mol.105.017970","article-title":"Interaction of d-tubocurarine with potassium channels: molecular modeling and ligand binding","volume":"69","author":"Rossokhin","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"16","key":"10.1016\/j.bioorg.2022.105904_b0530","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2022.105904_b0535","doi-asserted-by":"crossref","unstructured":"W. Humphrey, A. Dalke, K. Schulten, VMD: visual molecular dynamics, Journal of molecular graphics 14(1) (1996) 33-38, 27-28.","DOI":"10.1016\/0263-7855(96)00018-5"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105904_b0540","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"2\u20133","key":"10.1016\/j.bioorg.2022.105904_b0545","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-0270(91)90164-U","article-title":"Vibrodissociation of sliced mammalian nervous tissue","volume":"38","author":"Vorobjev","year":"1991","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105904_b0550","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-0270(96)00097-0","article-title":"A simple perfusion system for patch-clamp studies","volume":"68","author":"Vorobjev","year":"1996","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bioorg.2022.105904_b0555","unstructured":"M. Westerfield, The zebrafish book: a guide for the laboratory use of zebrafish, http:\/\/zfin. org\/zf_info\/zfbook\/zfbk. html (2000)."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105904_b0560","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.coph.2004.04.005","article-title":"Zebrafish as a pharmacological tool: the how, why and when","volume":"4","author":"Goldsmith","year":"2004","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822003091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822003091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:33:44Z","timestamp":1758616424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822003091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":112,"alternative-id":["S0045206822003091"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105904","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of avermectin\u2013imidazo[1,2-a]pyridine hybrids as potent GABAA receptor modulators","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105904"}}